Evidence map›Paper›PMID 35325408›Full record

ArticleFolia microbiologica2022

Construction of a recombinant food-grade Lactococcus lactis expressing P23 protein of Cryptosporidium parvum.

Xuehan Liu, Lei Deng, Wei Li, Zhijun Zhong, Ziyao Zhou, Guangneng Peng

Abstract read
PubMed Publisher
In one paragraph

Article in Folia microbiologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xuehan LiuCollege of Animal Science and Veterinary Medicine, Henan Institute of Science and Technology, Xinxiang, 453003, China. liuxuehan1986@126.com.ORCID http://orcid.org/0000-0002-8376-5580
Lei DengCollege of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Wei LiCollege of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Zhijun ZhongCollege of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Ziyao ZhouCollege of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China.
Guangneng PengCollege of Veterinary Medicine, Sichuan Agricultural University, Chengdu, 611130, China. pgn.sicau@163.com.
Sichuan Agricultural University · CN

Funding

the Chengdu Giant Panda Breeding Research Foundation CPF2014-10
6 · The paper itself

Abstract

Cryptosporidium parvum infects enterocytes in diverse vertebrates, including humans, and causes diarrheal illness. However, no effective drugs are available for this protozoan infection. The P23 protein of C. parvum is a protective antigen, considered a potential candidate for developing an effective vaccine against cryptosporidiosis. In this study, the complementary DNA (cDNA) of the p23 gene was subcloned to Escherichia coli DH5α, with one nucleotide difference. The constructed plasmid pNZ8149-P23 was transferred by electroporation to Lactococcus lactis NZ3900, and the recombinant L. lactis NZ3900/pNZ8149-P23 strain was screened in Elliker-medium by adding bromocresolpurple indicator. A 23-kDa protein was detected by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) after nisin induction in LM17 broth medium, suggesting that P23 protein was in the form of glycosylation. Simultaneously, an optimal induction time of 9 h was determined, and the density of OD

Indexed as

CryptosporidiosisCryptosporidiumCryptosporidium parvumLactococcus lactisAnimalsHumansPyridinolcarbamateRecombinant ProteinsPyridinolcarbamateRecombinant Proteins

Identifiers

PMID35325408
OpenAlexW4220996569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.